NewsRx

Search our medical news database

Accellent Corp.

Contract research organization prices cash tender offer

Published in Health Business Week, December 2nd, 2005

Accellent Corp. announced that it has priced its previously announced cash tender offer and consent solicitation for any and all of its outstanding $175,000,000 aggregate principal amount of 10% senior subordinated notes due 2012 (CUSIP No. 58455RAB4).

The tender offer consideration for each $1000 principal amount of notes validly tendered and accepted for purchase and not validly withdrawn is $1,137.01.

The offer to purchase and consent solicitation statement, and related consent and letter of transmittal, both dated October 21, 2005, more fully describe the terms of Accellent's tender offer to purchase any and all of the outstanding notes and its...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook